Skip to main content

TATDN1 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88411

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-88411

Key Product Details

Species Reactivity

Mouse

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of mouse TATDN1. Peptide sequence: TDPMFRGIYRGVQKHQDDLQDVIERAIQIGVKKFMITGGSLQDSKDALQL The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for TATDN1 Antibody

Western Blot: TATDN1 Antibody [NBP2-88411]

Western Blot: TATDN1 Antibody [NBP2-88411]

Western Blot: TATDN1 Antibody [NBP2-88411] - Host: Rabbit. Target Name: TATDN1. Sample Tissue: Mouse Kidney lysates. Antibody Dilution: 1ug/ml

Applications for TATDN1 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: TATDN1

Alternate Names

CDA11, EC 3.1.21, EC 3.1.21.-, FLJ43280, Hepatocarcinoma high expression protein, putative deoxyribonuclease TATDN1, TatD DNase domain containing 1

Gene Symbol

TATDN1

Additional TATDN1 Products

Product Documents for TATDN1 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for TATDN1 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...